Anti-LCMV Nucleoprotein Antibody (VL-4) is rat-derived IgG2a kappa type antibody inhibitor, targeting to LCMV nucleoprotein. Anti-LCMV Nucleoprotein Antibody (VL-4) reacts with lymphocytic choriomeningitis virus (LCMV) nucleoprotein. Anti-LCMV Nucleoprotein Antibody (VL-4) stain LCMV-infected cell internally with no surface staining. Anti-LCMV Nucleoprotein Antibody (VL-4) can be used for the detections of immunofluorescence and flow cytometry in LCMV infection[1].
Molekulargewicht:
(150 kDa)
Reinheit:
99
Target-Kategorie:
Arenavirus
Anwendungsbeschreibung:
MCE Product type: Inhibitory Antibodies
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten